Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.36 |
| ▸ | CTSK | P43235 | 3/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.33 |
| ▸ | REN | P00797 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 2/20 | 0.31 |
| ▸ | SYK | P43405 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | KDM4A | O75164 | 1/20 | 0.30 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.30 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.30 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.30 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.30 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.30 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23295228 | 0.93 | CTSL (0.40) | CTSLCTSKACACBRENCTSS | |
| SCHEMBL20979888 | 0.93 | CTSL (0.40) | CTSLCTSKACACBRENCTSS | |
| SCHEMBL23323790 | 0.91 | CTSL (0.33) | CTSLCTSKACACBREN | |
| SCHEMBL23323960 | 0.90 | CTSL (0.40) | CTSLCTSKACACBRENCTSS | |
| SCHEMBL23325354 | 0.89 | CTSL (0.37) | CTSLCTSKACACBRENCTSS | |
| SCHEMBL20979758 | 0.88 | CTSL (0.41) | CTSLCTSKACACBRENCTSS | |
| SCHEMBL20979804 | 0.88 | CTSL (0.37) | CTSLCTSKACACBRENCTSS | |
| SCHEMBL20979761 | 0.87 | CTSL (0.39) | CTSLCTSKACACBRENCTSS | |
| SCHEMBL19066715 | 0.85 | REN (0.38) | CTSLCTSKACACBREN | |
| SCHEMBL28772188 | 0.85 | REN (0.38) | CTSLCTSKACACBREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210130315-A1 | METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES | BAYER ANIMAL HEALTH GMBH (DE) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130315-A1 | METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES | DNPEP, NPEPPS, PREP | CTSL 799/4885CTSK 669/4885ACACB 2067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.